Aiea, HI, United States of America

Elise Ishida

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Elise Ishida: Pioneering Monoclonal Antibodies

Introduction: Elise Ishida, an accomplished inventor based in Aiea, Hawaii, has made significant contributions to the field of biomedical science through her innovative work on monoclonal antibodies. With two patents to her name, Ishida's research is focused on developing high-affinity antibodies that have the potential to advance medical therapeutics.

Latest Patents: Ishida's most notable patents revolve around high-affinity capsule-specific human monoclonal antibodies. These patents detail the provision of high-affinity capsule-specific antibodies and fragments, alongside methods, uses, and devices that incorporate these antibodies and fragments. The advancements made in these patents could lead to improved diagnostic and therapeutic applications in medical science.

Career Highlights: Elise Ishida is currently affiliated with the Albert Einstein College of Medicine, where she continues her pioneering research. Her expertise and innovative approach contribute significantly to the scientific community and enhance the understanding of monoclonal antibody applications.

Collaborations: During her career, Elise has collaborated with esteemed colleagues, including Jacqueline Michele Achkar and Jonathan R. Lai. These partnerships enable her to expand the scope of her research and incorporate diverse perspectives into her work.

Conclusion: Through her inventive spirit and dedication, Elise Ishida has carved a niche for herself in the realm of medical innovations. Her patents on high-affinity monoclonal antibodies reflect her commitment to advancing science and improving healthcare outcomes. As her career progresses, the impact of her work on the medical field is sure to grow, inspiring future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…